Group Training for Social Skills in Psychosis

Exploring the Feasibility of Social Skills Training in People With Psychosis.

Status

Completed

Phases

Study type

Interventional

Source

ClinicalTrials.gov

Registry ID

NCT02181777

Acronym

GRASP

Enrollment

Registered

2014-07-04

Start date

2014-03-31

Completion date

2016-11-30

Last updated

2021-09-05

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Psychotic Disorders

Keywords

Psychosis, Schizophrenia, Social Skills, Therapy

Brief summary

The purpose of this study is to assess the feasibility of a social skills training group for people with psychosis.

Detailed description

This study is assessing the feasibility of a psychological intervention targeting social cognition problems in people with psychosis. The intervention is a group psychological treatment facilitated by a clinical psychologist. The group therapy takes advantage of audiovisual material and practical exercises to illustrate strategies and thinking styles that may help participants overcome difficulties in social settings. A second objective of this study is to test a new method to measure social cognition by using portable devices. These devices will be carried by participants in their everyday life and will ask about their social activity levels at random times and record activity levels.

Interventions

BEHAVIORALGRASP

GRoup trAining for Social skills in Psychosis

BEHAVIORALStandard care

Treatment as usual

Study design

Allocation

RANDOMIZED

Intervention model

PARALLEL

Primary purpose

TREATMENT

Masking

SINGLE (Outcomes Assessor)

Eligibility

Sex/Gender

ALL

Age

18 Years to 65 Years

Healthy volunteers

Inclusion criteria

* Diagnosis part of the psychosis spectrum (according to DSM-IV or DSM-V or ICD-10) * Good command of the English language * Social engagement problems as evidenced by care coordinator report and number of hours spent in social activities per week lower than 10.

Exclusion criteria

* Primary diagnosis of substance abuse disorder * Change in antipsychotic medication in the last six weeks * Significant learning difficulties (premorbid IQ lower than 70)

Design outcomes

Primary

Measure	Time frame
Therapy drop-out rate	8 weeks post randomisation
Number of therapy session attended	8 weeks post randomisation

Countries

United Kingdom

Outcome results

None listed

Source: ClinicalTrials.gov · Data processed: Feb 4, 2026